Avatar Therapeutics
AAVATAR Therapeutics is a biotechnology company focused on innovative gene therapy solutions using an AAV (adeno-associated virus) gene therapy platform. The company develops effective and economical gene therapies for rare and intractable diseases, including lysosomal storage disorders (LSD), hereditary hearing loss, central nervous system diseases, and ocular diseases. Their platform uses AI-based technology to design and produce customized AAV vectors tailored to specific therapeutic goals and target diseases. AAVATAR Therapeutics offers a one-stop service from diagnosis, customized therapy design, AAV engineering, to production. The company has secured strategic investments and government support, reflecting strong market trust and growth potential as a global bio company. Their business model includes platform technology licensing and contract manufacturing for gene therapies.
Avatar Therapeutics
AAVATAR Therapeutics is a biotechnology company focused on innovative gene therapy solutions using an AAV (adeno-associated virus) gene therapy platform. The company develops effective and economical gene therapies for rare and intractable diseases, including lysosomal storage disorders (LSD), hereditary hearing loss, central nervous system diseases, and ocular diseases. Their platform uses AI-based technology to design and produce customized AAV vectors tailored to specific therapeutic goals and target diseases. AAVATAR Therapeutics offers a one-stop service from diagnosis, customized therapy design, AAV engineering, to production. The company has secured strategic investments and government support, reflecting strong market trust and growth potential as a global bio company. Their business model includes platform technology licensing and contract manufacturing for gene therapies.